20-22 May, 2025,
Steigenberger Wiltcher's, Brussels
Join Latham & Watkins at EU Pharmaceutical Law Forum 2024
You're Invited to EU Pharma Law with an Exclusive 10% Off
We are excited to announce that Latham & Watkins will be participating at the EU Pharmaceutical Law Forum on 21-23 May 2024 at the Steigenberger Wiltcher's Hotel, Brussels. And, we are pleased to let you know that as a valued client of Latham & Watkins, we have an exclusive 10% discount* for you. Your VIP discount code is: P24LATHAMWATKINS
*T&C's Apply
PANEL Merger Control and Expanded Jurisdictional Reach Developments and Strategy
Review of recent pharmaceutical merger control cases and authority approach
Article 22: the latest on Illumina/ Grail and implications for merger control strategy
Review of wider merger control cases: Pfizer/ Seagen and implications of Towercast judgments
Comparison of EU developments to global trends in merger control
How does merger control fit into overall regulatory scrutiny of the pharmaceutical industry?
Practical commercial implications when planning for commercial deals
PRESENTED BY:
Opening Remarks from Morning Chair
KEYNOTE PANEL Exploring Progress on Proposals in the EU Pharmaceutical Legislation Revision
Recent developments in the legislative process - EU Parliament
Evaluating the impact of legislative revisions on Europe's competitiveness and investment landscape
Update of the incentive schemes and a holistic assessment of regulatory challenges from the EU Pharmaceutical Package (paediatrics, investigation plans, AMR)
Implications of the requirements for a shortage prevention plan for medicines and APIs
Examining developments and benefits for a regulatory sandbox
Repurposing existing products and requirements for registration of new indications by MA holder